Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: The cocoa, cognition, and aging (CoCoA) study-A randomized controlled trial

American Journal of Clinical Nutrition

Volumn 101, Issue 3, 2015, Pages 538-548

  Mastroiacovo, Daniela ^a   Kwik Uribe, Catherine ^b   Grassi, Davide ^c   Necozione, Stefano ^c   Raffaele, Angelo ^a   Pistacchio, Luana ^a   Righetti, Roberta ^a   Bocale, Raffaella ^d   Lechiara, Maria Carmela ^a   Marini, Carmine ^c   Ferri, Claudio ^c   Desideri, Giovambattista ^a,c  

^a SS Filippo e Nicola Hospital   (Italy)

^b MARS INC   (United States)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d School of Medicine   (Italy)

Author keywords

Blood pressure; Cocoa flavanols; Cognitive function; Insulin resistance; Lipid peroxidation

Indexed keywords

FLAVANOL DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; FLAVONOL DERIVATIVE; NOOTROPIC AGENT;

AGED; ARTICLE; ASSESSMENT OF HUMANS; BLOOD PRESSURE REGULATION; BODY MASS; BODY WEIGHT; CACAO; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERVENTION STUDY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; TRIACYLGLYCEROL BLOOD LEVEL; VERBAL FLUENCY TEST; ADVERSE EFFECTS; AGING; BEVERAGE; CHEMISTRY; COHORT ANALYSIS; COMPARATIVE STUDY; DAIRY PRODUCT; DIET THERAPY; FOLLOW UP; HYPERTENSION; METABOLISM; MILD COGNITIVE IMPAIRMENT; MULTIMODALITY CANCER THERAPY; VERY ELDERLY;

THEOBROMA CACAO;

AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BEVERAGES; CACAO; COGNITION; COHORT STUDIES; COMBINED MODALITY THERAPY; DAIRY PRODUCTS; DOUBLE-BLIND METHOD; FEMALE; FLAVONOLS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MILD COGNITIVE IMPAIRMENT; NOOTROPIC AGENTS;

EID: 84928902456     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.092189     Document Type: Article

References (45)

1. Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol 2009;60:173-96.
2. Williams KN, Kemper S. Exploring interventions to reduce cognitive decline in aging. J Psychosoc Nurs Ment Health Serv 2010;48:42-51.
3. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-713.
4. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol 2012;32:2060-7.
5. Uranga RM, Bruce-Keller AJ, Morrison CD, Fernandez-Kim SO, Ebenezer PJ, Zhang L, Dasuri K, Keller JN. Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem 2010;114:344-61.
6. Morris MC. Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc 2012;71:1-13.
7. Kuriyama S, Hozaka A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. Am J Clin Nutr 2006;83:355-61.
8. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF, Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 2007;165:1364-71.
9. Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 2009;139:120-7.
10. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JPE. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008;3:115-26.
11. Schmitt-Schillig S, Schaffer S, Weber CC, Eckert GP, Müller WE. Flavonoids and the aging brain. J Physiol Pharmacol 2005;56(Suppl 1):23-36.
12. Williams RJ, Spencer JPE. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 2012;52:35-45.
13. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, Blumberg JB, Ferri C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 2008;138:1671-6.
14. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB, Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005;46:398-405.
15. Sorond FA, Lipsitz LA, Hollenberg NK, Fisher NDL. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat 2008;4:433-40.
16. Francis ST, Head K, Morris PG, MacDonald IA. The effect of flavanolrich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 2006;47:S215-20.
17. Heiss C, Keen CL, Kelm M. Flavanols and cardiovascular disease prevention. Eur Heart J 2010;31:2583-92.
18. Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, Raffaele A, Ferri L, Bocale R, Lechiara MC, et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) Study. Hypertension 2012;60:794-801.
19. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012;95:740-51.
20. Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 2012;8:CD008893.
21. Wiswedel I, Hirsch D, Kropf S, Gruening M, Pfister E, Schewe T, Sies H. Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med 2004;37:411-21.
22. Burt DB, Zembar MJ, Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 1995;117:285-305.
23. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
24. Gaddi A, Cicero AF, Wani FO, Dormi A, Pasquarelli V, D'Addato S. The realization of a project aimed at reducing the plasmatic lipid level in a large Italian population improves the mean calcium daily intake: the Brisighella Study. Eur J Clin Nutr 2001;55:97-106.
25. Knaze V, Zamora-Ros R, Luja'n-Barroso L, Romieu I, Scalbert A, Slimani N, Riboli E, van Rossum CTM, Bas Bueno-de-Mesquita H, Trichopoulou A, et al. Intake estimation of total and individual flavan- 3-ols, proanthocyanidins and thea flavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 2012;108:1095-108.
26. Vogiatzoglou A, Mulligan AA, Luben RN, Lentjes MA, Heiss C, Kelm M, Merx MW, Spencer JP, Schroeter H, Kuhnle GG. Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr 2014;111:1463-73.
27. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
28. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-6.
29. Borkowski J, Benton A, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-40.
30. Patrono C, Fitzgerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997;17:2309-15.
31. Levine TR, Hullett CR. Eta squared, partial eta squared, and misreporting of effect size in communication research. Hum Commun Res 2002;28:612-25.
32. Scholey A, Owen L. Effects of chocolate on cognitive function and mood: a systematic review. Nutr Rev 2013;71:665-81.
33. Sokolov AN, Pavlova MA, Klosterhalfen S, Enck P. Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior. Neurosci Biobehav Rev 2013;37:2445-53.
34. Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JPE, Butler LT. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 2009;4:227-42.
35. Crews WD Jr., Harrison DW, Wright JW. A double-blind, placebocontrolled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 2008;87:872-80.
36. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin ML, Carrière I. Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. J Alzheimers Dis 2010;20:S161-6.
37. Smit HJ, Gaffan EA, Rogers PJ. Methylxanthines are the psychopharmacologically active constituents of chocolate. Psychopharmacology (Berl) 2004;176:412-9.
38. Neumann KF, Rojo L, Navarrete LP, Faras G, Reyes P, Maccioni RB. Insulin resistance and Alzheimer's disease: molecular links and clinical implications. Curr Alzheimer Res 2008;5:438-47.
39. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-38.
40. Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol 2010;24:1505-14.
41. Field DT, Williams CM, Butler LT. Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav 2011;103:255-60.
42. Pase MP, Scholey AB, Pipingas A, Kras M, Nolidin K, Gibbs A, Wesnes K, Stough C. Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial. J Psychopharmacol 2013;27:451-8.
43. Holt RR, Heiss C, Kelm M, Keen CL. The potential of flavanol and procyanidin intake to influence age-related vascular disease. J Nutr Gerontol Geriatr 2012;31:290-323.
44. Skeie G, Braaten T, Hjartåker A, Lentjes M, Amiano P, Jakszyn P, Pala V, Palanca A, Niekerk EM, Verhagen H, et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 2009;63: S226-38.
45. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024-9.